Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study
about
Postmastectomy radiation therapy after neoadjuvant chemotherapy: review and interpretation of available dataThe combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: a systematic reviewRecent advances in the surgical care of breast cancer patients.Management of the Positive Axilla in 2017Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis.ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy.Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).Feasibility of sentinel lymph node biopsy in breast cancer patients with initial axillary lymph node metastasis after primary systemic therapy.Targeting and limiting surgery for patients with node-positive breast cancer.The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-AnalysisSentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?Sentinel lymph node biopsy does not apply to all axillary lymph node-positive breast cancer patients after neoadjuvant chemotherapyWhat is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancerImproved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary DissectionIntraoperative molecular analysis of sentinel lymph nodes following neoadjuvant chemotherapy in patients with clinical node negative breast cancer: An institutional studyReliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients.Neoadjuvant chemotherapy for early breast cancer.Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.Current status of sentinel lymph-node biopsy in patients with breast cancer.Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities.Neoadjuvant systemic treatment of breast cancer.Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer.Surgical considerations in patients receiving neoadjuvant systemic therapy.Application of ACOSOG Z0011 criteria reduces perioperative costs.Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.Sentinel node biopsy for breast cancer: past, present, and future.Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used.Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients.Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer.Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy.Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.Trends and controversies in multidisciplinary care of the patient with breast cancer.The Optimal Treatment Plan to Avoid Axillary Lymph Node Dissection in Early-Stage Breast Cancer Patients Differs by Surgical Strategy and Tumor Subtype.Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update.Local therapies for breast cancer.Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition.
P2860
Q26769835-2F0876FD-7334-4EB5-BA25-D147065F1375Q28079113-8141F7B9-D583-40A6-9DB8-88848B24CD8BQ33687673-A1B3DF97-0F11-4485-8BB1-33D50F1DAFA5Q33752466-A199306D-92BE-4467-9CAB-26A8129D5680Q34165928-13A39DA3-910A-415B-8627-1C7A0005FF5EQ34680978-57BEC007-66BC-4164-A924-803233C7D0B5Q35073164-FBCF70F9-5068-44CB-AC90-6985A77459BAQ35142216-A1FFDCBC-D856-474F-8FD5-39DCFCF52E42Q35673614-7AAD88D8-523D-4064-BFFF-C215A172E581Q36126195-1B39AF72-60EE-4008-8F80-68C6098D5348Q36363622-D7AF0FBA-081F-4181-B9EB-02E4B6197C7AQ36439409-D312441C-B0D6-4E92-92D6-3E6E5F66A271Q36738511-FCF662ED-E2EC-4B2C-AC77-896FA6D1BFDFQ36816914-C0C5CA29-9323-4243-80C3-27E5241394EDQ37065621-532C158E-012D-4B23-83A8-ED8EC26B0717Q37406726-77E55CF0-C22E-47A1-A211-D321442F7C8FQ37484630-301230F7-8728-477D-8028-10F577607F74Q37510892-E49DD33C-5145-4232-847C-9E6691D62B12Q37746916-BD15371D-1F4F-4518-B816-88F17FDE4558Q37746987-B93E3C63-587E-472D-827E-01E48852AD6EQ37779270-1DA2BD66-F772-4407-B34C-D193F27EE884Q37832409-7DBB2892-E2BF-45D0-AA81-D312BDEED515Q37845317-D0E08D95-7748-4A33-A406-A44911F62F2AQ37848740-0719DC26-2043-4501-B837-BCA92A60F64AQ37992692-DC58DF96-01CB-4B7F-B34C-412AAB9AB5BEQ38046426-D2C9B6B4-A582-4371-BDF8-B8FD7FD836ECQ38049473-90E8FE97-976A-4815-9FB3-E45990BF0077Q38068375-55D9D23E-414D-45D7-901D-06FCD94A315BQ38180308-9D3D908B-653F-4E78-86F0-604D57D04FC5Q38206273-ADB1DECE-55CE-49DC-BC3D-92690ADFCA00Q38366389-7B869CCA-9BCA-462D-A631-766F6706AA4FQ38409756-5A0508DF-58B4-47F6-9870-7E2177DF69F7Q38647498-43862842-A930-419F-B4EC-62F2C3F68586Q39029485-B320F948-1A57-41DE-A90F-382CD4261E5EQ39119467-681B57C0-9B37-4C9B-BD01-340F230613D0Q40100099-DF088F28-57FA-44D1-BEF8-08DE64DE77DEQ41849290-5326D8A5-109C-40D0-99C9-EAC63BCE57A8Q42028093-F27FD1F2-E584-4A2E-9629-B11CF2AE7E97Q45343269-F9068F45-BAF5-4625-86B1-C8F160243057Q48875015-9895E248-ACFF-4678-894B-804A318D74C0
P2860
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study
description
article
@en
im Februar 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2009
@uk
name
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@en
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@nl
type
label
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@en
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@nl
prefLabel
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@en
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@nl
P2093
P356
P1476
Sentinel Lymph Node Biopsy Aft ...... Prospective Multicentric Study
@en
P2093
Christine Sagan
François Dravet
Gilles Body
Herve Mignotte
Jean Leveque
Jean-Marc Classe
Pierre François Dupre
Sylvia Giard
Virginie Bordes
P304
P356
10.1200/JCO.2008.18.3228
P407
P50
P577
2009-02-10T00:00:00Z